These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8189856)

  • 1. [Guillain-Barré syndrome in CMV infection. Infectious and neurologic improvement with ganciclovir].
    Lindsten H; Binzer M; Boman J; Juto P
    Lakartidningen; 1994 Mar; 91(12):1227-8. PubMed ID: 8189856
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of Guillain-Barré syndrome associated with anti-GM2 antibody due to cytomegalovirus infection--special reference to the effect of ganciclovir].
    Niwa K; Kitagawa Y; Ohta T; Shinohara Y; Saito T
    Rinsho Shinkeigaku; 1995 Jun; 35(6):652-6. PubMed ID: 8521643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guillain-Barré syndrome associated with cytomegalovirus infection after kidney transplantation].
    Lloveras JJ; Larrue V; Delisle MB; Tack I; Icart J; Dupré C; Ton That H; Durand D; Suc JM
    Presse Med; 1994 Jun; 23(21):976-8. PubMed ID: 7937644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome associated with cytomegalovirus infection.
    Hart IK; Kennedy PG
    Q J Med; 1988 May; 67(253):425-30. PubMed ID: 2851853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guillain-Barré syndrome caused by cytomegalovirus at 40 days of age].
    Calvo Rey C; González de Dios J; Lajo Plaza A; Martínez Bermejo A; Montilla Bono J
    An Esp Pediatr; 1990 Nov; 33(5):481-4. PubMed ID: 1965770
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports.
    Manfredi R; Mastroianni A; Coronado OV; Chiodo F
    Recenti Prog Med; 1996 Nov; 87(11):545-8. PubMed ID: 9122537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganciclovir treatment of systemic cytomegalovirus in an immunocompetent host.
    Leman JS; Toalson TW; Wlodaver CG
    J Okla State Med Assoc; 1997; 90(7):367-9. PubMed ID: 9379249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
    Parente F; Bianchi Porro G
    Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid diagnosis of cytomegalovirus in the cerebrospinal fluid of a patient with AIDS-associated polyradiculopathy.
    Marmaduke DP; Brandt JT; Theil KS
    Arch Pathol Lab Med; 1991 Nov; 115(11):1154-7. PubMed ID: 1660706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors.
    Shah T; Lai WK; Mutimer D
    Transpl Infect Dis; 2005 Jun; 7(2):57-62. PubMed ID: 16150091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of gancyclovir and HAART administration in the treatment of a rare complication of HIV disease: cytomegalovirus-associated Guillain-Barré syndrome.
    Calza L; Manfredi R; Marinacci G; Briganti E; Giuliani R; Talo S; Chiodo F
    J Chemother; 2001 Oct; 13(5):575-7. PubMed ID: 11760224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barré syndrome associated with acute cytomegalovirus mononucleosis syndrome.
    Mozes B; Pines A; Sayar Y; Kaplinsky N; Frankl O
    Eur Neurol; 1984; 23(4):237-9. PubMed ID: 6092090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ganciclovir approved for CMV.
    Common Factor; 1995 Apr; (no 10):21. PubMed ID: 11362347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient.
    Puliyanda DP; Silverman NS; Lehman D; Vo A; Bunnapradist S; Radha RK; Toyoda M; Jordan SC
    Transpl Infect Dis; 2005 Jun; 7(2):71-4. PubMed ID: 16150094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral ganciclovir.
    Schouten JT
    STEP Perspect; 1995; 7(3):1, 11. PubMed ID: 11362979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ; Zaas AK; Hanson KE; Palmer SM
    J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ganciclovir-resistant cytomegalovirus infection: 2 cases with different clinical impact].
    Reusser P; Hostettler B; Attehbofer R
    Schweiz Med Wochenschr; 1996 Oct; 126(42):1779-84. PubMed ID: 8966510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Generalized intestinal CMV infection with protein-losing syndrome in ulcerative colitis].
    Kraus M; Meyenberger C; Suter W
    Schweiz Med Wochenschr; 2000 Oct; 130(43):1600-5. PubMed ID: 11100513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral ganciclovir approved.
    Gold D
    GMHC Treat Issues; 1995 Jan; 9(1):10. PubMed ID: 11367376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome associated with cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
    Hernández-Boluda JC; Lis MJ; Goterris R; Arbona C; Terol MJ; Tormo M; Solano C
    Transpl Infect Dis; 2005 Jun; 7(2):93-6. PubMed ID: 16150099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.